TY  - GEN
AU  - Dorman,Susan E
AU  - Nahid,Payam
AU  - Kurbatova,Ekaterina V
AU  - Goldberg,Stefan V
AU  - Bozeman,Lorna
AU  - Burman,William J
AU  - Chang,Kwok-Chiu
AU  - Chen,Michael
AU  - Cotton,Mark
AU  - Dooley,Kelly E
AU  - Engle,Melissa
AU  - Feng,Pei-Jean
AU  - Fletcher,Courtney V
AU  - Ha,Phan
AU  - Heilig,Charles M
AU  - Johnson,John L
AU  - Lessem,Erica
AU  - Metchock,Beverly
AU  - Miro,Jose M
AU  - Nhung,Nguyen Viet
AU  - Pettit,April C
AU  - Phillips,Patrick P J
AU  - Podany,Anthony T
AU  - Purfield,Anne E
AU  - Robergeau,Kathleen
AU  - Samaneka,Wadzanai
AU  - Scott,Nigel A
AU  - Sizemore,Erin
AU  - Vernon,Andrew
AU  - Weiner,Marc
AU  - Swindells,Susan
AU  - Chaisson,Richard E
TI  - High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
SN  - 1559-2030
PY  - 2021///0519
KW  - Adolescent
KW  - Adult
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Young Adult
KW  - Antitubercular Agents
KW  - administration & dosage
KW  - Directly Observed Therapy
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Equivalence Trials as Topic
KW  - Ethambutol
KW  - therapeutic use
KW  - HIV Infections
KW  - epidemiology
KW  - Moxifloxacin
KW  - Rifampin
KW  - Tuberculosis, Pulmonary
KW  - drug therapy
KW  - Multicenter Studies as Topic
KW  - Clinical Trials, Phase III as Topic
N1  - Publication Type: Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1016/j.cct.2020.105938
ER  -